Latka logo
BioAge Labs logo

BioAge Labsrevenue & market cap

Emeryville, CaliforniaCEO Kristen Fortney

Public company

BioAge Labs is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging.

bioagelabs.comLinkedInUpdated Sep 28, 2026
Annual revenue
$9M
Dec 2025 · Stock Analysis
Market cap
$329.5M
Sep 2026

BioAge Labs revenue

BioAge Labs' annual revenue was $9M in December 2025 (Stock Analysis).

$0
$2.5M
$5M
$7.5M
$9M
2025
ReportedEvery reading has its own bar
As ofRevenueSource
Dec 2025$9MStock Analysis

BioAge Labs market cap

BioAge Labs is a public company. Its market capitalisation was $329.5M in September 2026.

BioAge Labs CEO

Kristen Fortney is CEO of BioAge Labs.

BioAge Labs FAQ

What is BioAge Labs' revenue?

BioAge Labs' annual revenue was $9M in December 2025, according to Stock Analysis.

Is BioAge Labs publicly traded?

Yes. BioAge Labs is a public company, with a market capitalisation of $329.5M in September 2026.

Who is the CEO of BioAge Labs?

Kristen Fortney is the CEO of BioAge Labs.

Categories

How this page is sourced

1 from public sources. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 28, 2026Data disclaimerReport a correctionClaim this profileRun BioAge Labs? Join the podcast